We aim to provide the most meaningful outcomes for patients with ulcerative colitis and Crohn’s disease. Learn about the current initiatives in IBD care.more
Gone are the days when unnecessarily laborious processes and committees stifled creativity in research. At pRED, we don’t believe in keeping the best brains in boxes. If our scientists have a great idea, we’ll make sure that they have the flexibility, resources and multi-disciplinary expertise they need to try it out, fast. Only by doing this can we produce the innovation society desperately needs, and at the same time quickly rule out unsuccessful hypotheses.
Here is a flavour of the areas that excite us.
Inflammatory bowel diseases
Cardiovascular and metabolism
Our medical innovations treat cardiovascular and metabolism diseases such as heart attacks and diabetes.more
Haemophilia A is an inherited bleeding disorder where a person’s blood does not clot properly, leading in severe cases to uncontrolled bleeding, either spontaneously or after minor trauma.more
We're advancing our expertise in Immunology and discovering and developing innovative medicines for patients living with severe respiratory and autoimmune diseases.more
With one of the strongest pipelines in the industry, Roche Neuroscience is developing medicines for a range of serious neurological diseases, including multiple sclerosis, Alzheimer’s disease, autism, spinal muscular atrophy, depression, Parkinson’s disease, Down syndrome.more
Our scientists take a rigorous, comprehensive approach to understanding cancer biology and drug discovery.more
Rare diseases have a huge impact on individuals and their families and society as a whole, yet treatments are available for only around 200 rare diseases.more
Working in both Pharmaceuticals and Diagnostics, we are uniquely positioned to fit the treatment to the patients.more